LAKEN LASHER: Open Payments
NPI 1396315859 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 80 payments from 14 companies in 2025. Trend: 2023 $813 · 2024 $1,258 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $285 |
| Corium, LLC | 14 | $180 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $135 |
| Novo Nordisk Inc | 5 | $121 |
| Otsuka America Pharmaceutical, Inc. | 5 | $115 |
| Amgen Inc. | 3 | $53 |
| Collegium Pharmaceutical, Inc. | 3 | $51 |
| PFIZER INC. | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Tris Pharma Inc | 1 | $23 |
Products named: Azstarys, QULIPTA, REXULTI, CAPLYTA, Wegovy, UBRELVY, VRAYLAR, Jornay PM.
Industry payments across KY — which companies pay providers there.
